The Healthea Group is a European network of CDMOs created in 2025 from the alliance of leading companies in the healthcare and life science sectors. Backed by over 40 years of collective experience, the Group offers one of the most comprehensive and versatile manufacturing capabilities on the market.
With 5 production sites covering 26,000 sqm, The Healthea Group develops and manufactures various pharmaceutical forms, including medical devices, cosmetics, food supplements, and FSMPs.
The Group integrates:
✔️ 2 in-house R&D laboratories
✔️ An accredited microbiology lab
✔️ Over 30 medical devices across 14 therapeutic areas
✔️ A catalogue of ready-to-market products, including patent-pending formulations and ongoing clinical trials
Our origins trace back over 20 years to a strategic brand acquisition, and in 2023 the partnership with Riverside marked a new chapter—bringing together companies with proven expertise to shape a stronger, more agile CDMO group.
The Group includes:
🔹 Biodue
🔹 Farcoderma
🔹 Healthea Licensing (acquired from a long-established Medical Device company)
With a strong commitment to quality, innovation, and flexibility, The Healthea Group is the ideal partner for businesses looking for a fully integrated and scalable CDMO solution in Europe.
